Skip to main content
SpringerLink
Log in

Anti-inflammatory Therapies for Sensorineural Hearing Loss

  • Chapter
  • First Online:
Inflammatory Mechanisms in Mediating Hearing Loss

Abstract

Anti-inflammatory and immunosuppressive therapies have been widely employed in the treatment of sensorineural hearing loss in the context of autoimmune inner ear disease (AIED) and idiopathic sudden sensorineural hearing loss (ISSHL). While steroids are the mainstay of treatment for these disorders, numerous other therapies, including cyclophosphamide, methotrexate, azathioprine, rituximab, anakinra, anti- TNF-α agents, and plasmapharesis have been investigated. Here we will describe the most commonly-studied of these immune-modulating therapies and review the evidence for their efficacy in the treatment of inner ear disorders, focusing on AIED and ISSHL. Further investigation of the potential inflammatory mechanisms mediating these forms of sensorineural hearing loss may ultimately identify targets for future treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2009;4:CD003422.

    Google Scholar 

  • Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol. 2009;30(4):443–8.

    Article  PubMed  Google Scholar 

  • Alpa M, Bucolo S, Beatrice F, Giachino O, Roccatello D. Apheresis as rescue therapy in a severe case of sudden hearing loss. Int J Artif Organs. 2011;34(7):589–92.

    Article  PubMed  Google Scholar 

  • André R, Corlieu P, Crabol Y, Cohen P, Guillevin L. Infliximab reverses progressive deafness. Presse Med. 2015;44(6 Pt 1):675–7.

    Article  PubMed  Google Scholar 

  • Angeli SI, Abi-Hachem RN, Vivero RJ, Telischi FT, Machado JJ. L-N-acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. Acta Otolaryngol. 2012;132(4):369–76.

    Article  CAS  PubMed  Google Scholar 

  • Berrettini S, Ferri C, Ravecca F, LaCivita L. Progressive sensorineural hearing impairment in systemic vasculitides. Semin Arthritis Rheum. 1998;27(5):301–18.

    Article  CAS  PubMed  Google Scholar 

  • Brant JA, Eliades SJ, Ruckenstein MJ. Systematic review of treatments for autoimmune inner ear disease. Otol Neurotol. 2015;36(10):1585–92.

    Article  PubMed  Google Scholar 

  • Brookes GB, Newland AC. Plasma exchange in the treatment of immune complex-associated sensorineural deafness. J Laryngol Otol. 1986;100(1):25–33.

    Article  CAS  PubMed  Google Scholar 

  • Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum. 2004;34(2):544–8.

    Article  CAS  PubMed  Google Scholar 

  • Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope. 1977;87(5 Pt 1):817–25.

    Article  CAS  PubMed  Google Scholar 

  • Chen C-Y, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol. 2003;24(5):728.

    Article  PubMed  Google Scholar 

  • Clements MR, Mistry CD, Keith AO, Ramsden RT. Recovery from sensorineural deafness in Wegener’s granulomatosis. J Laryngol Otol. 1989;103(5):515–8.

    Article  CAS  PubMed  Google Scholar 

  • Cohen S, Shoup A, Weisman MH, Harris J. Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study. Otol Neurotol. 2005;26(5):903–7.

    Article  PubMed  Google Scholar 

  • Cohen S, Roland P, Shoup A, Lowenstein M, Silverstein H, Kavanaugh A, et al. A pilot study of rituximab in immune-mediated inner ear disease. Audiol Neurootol. 2011;16(4):214–21.

    Article  CAS  PubMed  Google Scholar 

  • Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg. 2007;133(6):582–6.

    Article  PubMed  Google Scholar 

  • Crane RA, Camilon M, Nguyen S, Meyer TA. Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laryngoscope. 2015;125(1):209–17.

    Article  PubMed  Google Scholar 

  • Derebery MJ, Fisher LM, Voelker CCJ, Calzada A. An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease. Otol Neurotol. 2014;35(9):1515–21.

    Article  PubMed  Google Scholar 

  • Di Leo E, Coppola F, Nettis E, Vacca A, Quaranta N. Late recovery with cyclosporine-A of an auto-immune sudden sensorineural hearing loss. Acta Otorhinolaryngol Ital. 2011;31(6):399–401.

    PubMed  Google Scholar 

  • Dowd A, Rees WD. Treatment of sensorineural deafness associated with ulcerative colitis. Br Med J (Clin Res Ed). 1987;295(6589):26.

    Article  CAS  Google Scholar 

  • Elidan J, Cohen E, Levi H. Effect of cyclosporine A on the hearing loss in Behçet’s disease. Ann Otol Rhinol Laryngol. 1991;100(6):464–8.

    Article  CAS  PubMed  Google Scholar 

  • Fetterman BL, Saunders JE, Luxford WM. Prognosis and Treatment of Sudden Sensorineural Hearing Loss. Otol Neurotol. 1996;17(4):529.

    CAS  Google Scholar 

  • Flammer JR, Rogatsky I. Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol. 2011;25(7):1075–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • García-Berrocal JR, Ramírez-Camacho R, Millán I, Górriz C, Trinidad A, Arellano B, et al. Sudden presentation of immune-mediated inner ear disease: characterization and acceptance of a cochleovestibular dysfunction. J Laryngol Otol. 2003;117(10):775–9.

    Article  PubMed  Google Scholar 

  • García-Berrocal JR, Ibáñez A, Rodríguez A, González-García JÁ, Verdaguer JM, Trinidad A, et al. Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: a physiopathologic approach. Eur Arch Otorhinolaryngol. 2006;263(11):977–82.

    Article  PubMed  Google Scholar 

  • Glasscock ME, Nechtman C, Altenau M. Sudden loss of hearing: a medical emergency. South Med J. 1971;64(12):1485–9.

    Article  PubMed  Google Scholar 

  • Gulleroglu K, Baskin E, Aydin E. Hearing status in pediatric renal transplant recipients. Exp Clin Transplant. 2015;13(4):324–8.

    PubMed  Google Scholar 

  • Hamblin TJ, Mufti GJ, Bracewell A. Severe deafness in systemic lupus erythematosus: its immediate relief by plasma exchange. Br Med J (Clin Res Ed). 1982;284(6326):1374.

    Article  CAS  Google Scholar 

  • Han CS, Park JR, Boo SH, Jo JM. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg. 2009;141(5):572–8.

    Article  PubMed  Google Scholar 

  • Harris JP, Sharp PA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope. 1990;100(5):516–24.

    Article  CAS  PubMed  Google Scholar 

  • Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA. 2003;290(14):1875–83.

    Article  CAS  PubMed  Google Scholar 

  • Harris DA, Mikulec AA, Carls SL. Autoimmune inner ear disease preliminary case report: audiometric findings following steroid treatments. Am J Audiol. 2013;22(1):120–4.

    Article  PubMed  Google Scholar 

  • Hatano M, Uramoto N, Okabe Y, Furukawa M, Ito DM. Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2009;128(2):116–21.

    Article  CAS  Google Scholar 

  • Hautefort C, Loundon N, Montchilova M, Marlin S, Garabedian EN, Ulinski T. Mycophenolate mofetil as a treatment of steroid dependent Cogan’s syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73(10):1477–9.

    Article  PubMed  Google Scholar 

  • Heywood RL, Hadavi S, Donnelly S. Infliximab for autoimmune inner ear disease: case report and literature review. J Laryngol Otol. 2013;127(11):1145–7.

    Article  CAS  PubMed  Google Scholar 

  • Hirose K, Wener MH, Duckert LG. Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope. 1999;109(11):1749–54.

    Article  CAS  PubMed  Google Scholar 

  • Hughes GB, Kinney SE, Barna BP, Calabrese LH. Practical versus theoretical management of autoimmune inner ear disease. Laryngoscope. 1984;94(6):758–67.

    Article  CAS  PubMed  Google Scholar 

  • Keithley EM, Wang X, Barkdull GC. Tumor necrosis factor α can induce recruitment of inflammatory cells to the cochlea. Otol Neurotol. 2008;29(6):854–9.

    Article  PubMed  Google Scholar 

  • Khalidi NA, Rebello R. Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review. J Laryngol Otol. 2008;122(12):1371–6.

    Article  CAS  PubMed  Google Scholar 

  • Kobayashi S, Fujishiro N, Sugiyama K. Systemic lupus erythematosus with sensorineural hearing loss and improvement after plasmapheresis using the double filtration method. Intern Med. 1992;31(6):778–81.

    Article  CAS  PubMed  Google Scholar 

  • Langford CA. Complications of cyclophosphamide therapy. Eur Arch Otorhinolaryngol. 1997;254(2):65–72.

    Article  CAS  PubMed  Google Scholar 

  • Lasak JM, Sataloff RT, Hawkshaw M. Autoimmune inner ear disease: steroid and cytotoxic drug therapy. Ear Nose Throat J. 2001;80(11):808–11.

    PubMed  CAS  Google Scholar 

  • Liu YC, Rubin R, Sataloff RT. Treatment-refractory autoimmune sensorineural hearing loss: response to infliximab. Ear Nose Throat J. 2011;90(1):23–8.

    PubMed  Google Scholar 

  • Lobo D, Trinidad A, García-Berrocal JR, Verdaguer JM, Ramírez-Camacho R. TNFα blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis. Eur Arch Otorhinolaryngol. 2006;263(7):622–6.

    Article  PubMed  Google Scholar 

  • Loveman DM, de Comarmond C, Cepero R, Baldwin DM. Autoimmune sensorineural hearing loss: clinical course and treatment outcome. Semin Arthritis Rheum. 2004;34(2):538–43.

    Article  CAS  PubMed  Google Scholar 

  • Luetje CM. Theoretical and practical implications for plasmapheresis in autoimmune inner ear disease. Laryngoscope. 1989;99(11):1137–46.

    Article  PubMed  Google Scholar 

  • Luetje CM, Berliner KI. Plasmapheresis in autoimmune inner ear disease: long-term follow-up. Otol Neurotol. 1997;18(5):572.

    CAS  Google Scholar 

  • Marioni G, Perin N, Tregnaghi A, Bellemo B. Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis. Acta Otolaryngol. 2004;124(5):603–7.

    Article  PubMed  Google Scholar 

  • Matsuoka AJ, Harris JP. Autoimmune inner ear disease: a retrospective review of forty-seven patients. Audiol Neurootol. 2013;18(4):228–39.

    Article  CAS  PubMed  Google Scholar 

  • Matteson EL, Tirzaman O, Kasperbauer J, Facer GW, Beatty CW, Fabry DA, et al. Use of methotrexate for autoimmune hearing loss. Ann Otol Rhinol Laryngol. 2000;109(8):710–4.

    Article  CAS  PubMed  Google Scholar 

  • Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, et al. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum. 2005;53(3):337–42.

    Article  CAS  PubMed  Google Scholar 

  • McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol. 1979;88(5):585–9.

    CAS  Google Scholar 

  • McClelland L, Powell RJ, Birchall J. Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss. Acta Otolaryngol. 2009;125(12):1356–60.

    Article  CAS  Google Scholar 

  • Merchant SN, Adams JC, Nadol JBJ. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2005;26(2):151.

    Article  PubMed  Google Scholar 

  • Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum. 2006;54(5):1697–700.

    Article  PubMed  Google Scholar 

  • Moscicki RA, Martin JES, Quintero CH, Rauch SD, Nadol JB, Bloch KJ. Serum antibody to inner ear proteins in patients with progressive hearing loss: correlation with disease activity and response to corticosteroid treatment. JAMA. 1994;272(8):611–6.

    Article  CAS  PubMed  Google Scholar 

  • Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope. 1984;94(5 Pt 1):664–6.

    PubMed  CAS  Google Scholar 

  • Niparko JK, Wang N-Y, Rauch SD, Russell GB, Espeland MA, Pierce JJ, et al. Serial audiometry in a clinical trial of AIED treatment. Otol Neurotol. 2005;26(5):908–17.

    Article  PubMed  Google Scholar 

  • Orsoni JG, Laganà B, Rubino P, Zavota L, Bacciu S, Mora P. Rituximab ameliorated severe hearing loss in Cogan’s syndrome: a case report. Orphanet J Rare Dis. 2010;5(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  • Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(S91):1–17.

    Article  CAS  PubMed  Google Scholar 

  • Pathak S, Goldofsky E, Vivas EX, Bonagura VR, Vambutas A. IL-1β Is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol. 2011;186(3):1870–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Plester D, Soliman AM. Autoimmune hearing loss. Otol Neurotol. 1989;10(3):188.

    CAS  Google Scholar 

  • Rahman MU, Poe DS, Choi HK. Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol. 2001;22(5):619.

    Article  CAS  PubMed  Google Scholar 

  • Rauch SD. Clinical Management of Immune-mediated Inner-ear Disease. Ann N Y Acad Sci. 1997;830(1):203–10.

    Article  CAS  PubMed  Google Scholar 

  • Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305(20):2071–9.

    Article  CAS  PubMed  Google Scholar 

  • Rifai K, Bahr MJ, Cantz T, Klempnauer J. Severe hearing loss after liver transplantation. Transplant Proc. 2005;37(4):1918–9.

    Article  CAS  PubMed  Google Scholar 

  • Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg. 2004;12(5):426.

    Article  PubMed  Google Scholar 

  • Ruckenstein MJ, Hu L. Antibody deposition in the stria vascularis of the MRL-Faslpr mouse. Hear Res. 1999;127(1–2):137–42.

    Article  CAS  PubMed  Google Scholar 

  • Ruckenstein MJ, Sarwar A, Hu L, Shami H, Marion TN. Effects of immunosuppression on the development of cochlear disease in the MRL-Fas Mouse. Laryngoscope. 1999;109(4):626–30.

    Article  CAS  PubMed  Google Scholar 

  • Ruckenstein MJ, Mount RJ, Harrison RV. The MRL-lpr/lpr mouse: a potential model of autoimmune inner ear disease. Acta Otolaryngol. 2009;113(2):160–5.

    Article  Google Scholar 

  • Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol. 2009;122(5):38–43.

    Article  Google Scholar 

  • Sabbagh El NG, Sewitch MJ, Bezdjian A, Daniel SJ. Intratympanic dexamethasone in sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope. 2016;88(suppl):524.

    Google Scholar 

  • Salley LH, Grimm M, Sismanis A, Spencer RF, Wise CM. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients. J Rheumatol. 2001;28(5):1037–40.

    PubMed  CAS  Google Scholar 

  • Sano H, Kamijo T, Ino T, Okamoto M. Edaravone, a free radical scavenger, in the treatment of idiopathic sudden sensorineural hearing loss with profound hearing loss. Auris Nasus Larynx. 2010;37(1):42–6.

    Article  PubMed  Google Scholar 

  • Saraçaydin A, Katircioğlu S, Katircioğlu S, Karatay MC. Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease. J Int Med Res. 2016;21(4):192–6.

    Article  Google Scholar 

  • Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM. Tumor necrosis factor-α, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope. 2002;112(9):1627–34.

    Article  CAS  PubMed  Google Scholar 

  • Scheinfeld N. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatol Treat. 2009;15(5):280–94.

    Article  CAS  Google Scholar 

  • Sharaf K, Ihler F, Bertlich M, Reichel CA, Berghaus A, Canis M. Tumor necrosis factor-induced decrease of cochlear blood flow can be reversed by etanercept or JTE-013. Otol Neurotol. 2016;37(7):e203–8.

    Article  PubMed  Google Scholar 

  • Sismanis A, Wise CM, Johnson GD. Methotrexate management of immune-mediated cochleovestibular disorders. Otolaryngol Head Neck Surg. 2016.

    Google Scholar 

  • Slattery WH, Fisher LM, Iqbal Z. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005;132(1):5–10.

    Article  PubMed  Google Scholar 

  • Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3 Suppl):S1–S35.

    Article  PubMed  Google Scholar 

  • Suckfüll M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet. 2002;360(9348):1811–7.

    Article  PubMed  Google Scholar 

  • Trune DR, Canlon B. Corticosteroid therapy for hearing and balance disorders. Anat Rec. 2012;295(11):1928–43.

    Article  CAS  Google Scholar 

  • Trune DR, Wobig RJ, Kempton JB, Hefeneider SH. Steroid treatment in young MRL.MpJ-Faslpr autoimmune mice prevents cochlear dysfunction. Hear Res. 1999a;137(1–2):167–73.

    Article  CAS  PubMed  Google Scholar 

  • Trune DR, Wobig RJ, Kempton JB, Hefeneider SH. Steroid treatment improves cochlear function in the MRL.MpJ-Faslpr autoimmune mouse. Hear Res. 1999b;137(1–2):160–6.

    Article  CAS  PubMed  Google Scholar 

  • Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res. 2006;212(1–2):22–32.

    Article  CAS  PubMed  Google Scholar 

  • Vambutas A, DeVoti J, Goldofsky E, Gordon M, Lesser M, Bonagura V. Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One. 2009;4(4):e5293.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vambutas A, Lesser M, Mullooly V, Pathak S, Zahtz G, Rosen L, et al. Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease. J Clin Invest. 2014;124(9):4115–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Van Wijk F, Staecker H, Keithley E, Lefebvre PP. Local perfusion of the tumor necrosis factor α blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol. 2006;11(6):357–65.

    Article  CAS  PubMed  Google Scholar 

  • Veldman JE, Hanada T, Meeuwsen F. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness a reappraisal of immune reactivity in inner ear disorders. Acta Otolaryngol. 1993;113(3):303–6.

    Article  CAS  PubMed  Google Scholar 

  • Vergles JM, Radic M, Kovacic J, Salamon L. Successful use of adalimumab for treating rheumatoid arthritis with autoimmune sensorineural hearing loss: two birds with one stone. J Rheumatol. 2010;37(5):1080–1.

    Article  Google Scholar 

  • Wang X, Truong T, Billings PB, Harris JP, Keithley EM. Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol. 2003;24(1):52.

    Article  PubMed  Google Scholar 

  • Westerlaken BO, Stokroos RJ, Wit HP, Dhooge IJM, Albers FWJ. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol. 2016;112(11):993–1000.

    Article  Google Scholar 

  • Whitaker S. Idiopathic sudden hearing loss. Otol Neurotol. 1980;1(3):180.

    CAS  Google Scholar 

  • Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol. 1980;106(12):772–6.

    Article  CAS  PubMed  Google Scholar 

  • Wilson WR, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2006;7:CD003998.

    Google Scholar 

  • Wu H-P, Chou Y-F, Yu S-H, Wang C-P, Hsu C-J, Chen P-R. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol. 2011;32(5):774–9.

    Article  PubMed  Google Scholar 

  • Yamazaki T, Masumoto J, Agematsu K, Sawai N, Kobayashi S, Shigemura T, et al. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum. 2008;58(3):864–8.

    Article  CAS  PubMed  Google Scholar 

  • Yang GSY, Song H-T, Keithley EM, Harris JP. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Otol Neurotol. 2000;21(4):499.

    CAS  Google Scholar 

  • Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg. 2003;128(1):92–8.

    Article  PubMed  Google Scholar 

  • Zeitoun H, Beckman JG, Arts HA. Corticosteroid response and supporting cell antibody in autoimmune hearing loss. Arch Otolaryngol Head Neck Surg. 2005;131(8):665–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA

    Alanna M. Windsor & Michael J. Ruckenstein

Authors
  1. Alanna M. Windsor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Ruckenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alanna M. Windsor .

Editor information

Editors and Affiliations

  1. Department of Pharmacology, School of Medicine, Southern Illinois University, Springfield, Illinois, USA

    Vickram Ramkumar

  2. Division of Otolaryngology, Department of Surgery, School of Medicine, Southern Illinois University, Springfield, Illinois, USA

    Leonard P. Rybak

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Windsor, A.M., Ruckenstein, M.J. (2018). Anti-inflammatory Therapies for Sensorineural Hearing Loss. In: Ramkumar, V., Rybak, L. (eds) Inflammatory Mechanisms in Mediating Hearing Loss. Springer, Cham. https://doi.org/10.1007/978-3-319-92507-3_10

Download citation

Publish with us

Policies and ethics

Search

Navigation